CRISPR gene editing is often hailed as a medical breakthrough, but I've been following recent studies and the off-target effects still scare me. A 2023 paper showed unintended mutations in 2% of edited cells, which could lead to cancer if those cells divide. We're talking about permanently altering a person's genome, so shouldn't we slow down on clinical trials until we can guarantee better precision?